These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7777107)

  • 1. Effect of glucose infusion on the renal transport of purine bases and oxypurinol.
    Moriwaki Y; Yamamoto T; Takahashi S; Suda M; Higashino K
    Nephron; 1995; 69(4):424-7. PubMed ID: 7777107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal clearances of purine bases and oxypurinol during glucose infusion.
    Moriwaki Y; Yamamoto T; Takahashi S; Nasako Y; Hada T; Higashino K
    Adv Exp Med Biol; 1994; 370():39-42. PubMed ID: 7660935
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of lactate infusion on renal transport of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
    Nephron; 1993; 65(1):73-6. PubMed ID: 8413795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol.
    Moriwaki Y; Yamamoto T; Tsutsumi Z; Takahashi S; Hada T
    Metabolism; 2002 Jul; 51(7):893-5. PubMed ID: 12077737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of DL-sodium lactate infusion on excretion of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):588-92. PubMed ID: 8314359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine metabolism in women with primary gout.
    Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil AA
    Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glucagon on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hiroishi K; Yamakita J; Nakano T; Higashino K
    J Rheumatol; 1997 Apr; 24(4):708-13. PubMed ID: 9101506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of furosemide on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthine-containing calculi during allopurinol therapy.
    Kranen S; Keough D; Gordon RB; Emmerson BT
    J Urol; 1985 Apr; 133(4):658-9. PubMed ID: 3981718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
    Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
    Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amino acids on the excretions of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Yamakita J; Higashino K
    Nephron; 1996; 73(1):41-7. PubMed ID: 8742955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide.
    Yamamoto T; Moriwaki Y; Takahashi S; Hada T; Higashino K
    Nephron; 1988; 48(2):116-20. PubMed ID: 3344050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol, and purine bases between dietary intake and fasting.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):157-62. PubMed ID: 8861734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    J Rheumatol; 2001 Oct; 28(10):2294-7. PubMed ID: 11669172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of losartan potassium, an angiotensin II receptor antagonist, on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    J Rheumatol; 2000 Sep; 27(9):2232-6. PubMed ID: 10990239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    Metabolism; 2001 Oct; 50(10):1230-3. PubMed ID: 11586499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine metabolism in female patients with primary gout.
    Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil A
    Adv Exp Med Biol; 1994; 370():69-72. PubMed ID: 7660998
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of excessive purine biosynthesis in hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Sorensen LB
    J Clin Invest; 1970 May; 49(5):968-78. PubMed ID: 5441549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of allopurinol and its metabolite oxypurinol after oral administration of allopurinol alone or associated with benzbromarone in man. Simultaneous assay of hypoxanthine and xanthine by gas chromatography-mass spectrometry.
    Lartigue-Mattei C; Chabard JL; Ristori JM; Bussiere JL; Bargnoux H; Petit J; Berger JA
    Fundam Clin Pharmacol; 1991; 5(7):621-33. PubMed ID: 1778540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal excretion of hypoxanthine and xanthine in primary gout.
    Puig JG; Mateos FA; Jiménez ML; Ramos TH
    Am J Med; 1988 Oct; 85(4):533-7. PubMed ID: 3177401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.